Synopsis
0
JDMF
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1440ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1920ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML ;105MG/100ML;3.5GM/100ML (2400ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML ;147MG/100ML;3.9GM/100ML (1026ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (1540ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2053ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2566ML)
USFDA APPLICATION NUMBER - 200656
Digital Content
DATA COMPILATION #PharmaFlow
Global Sales Information
Market Place
ABOUT THIS PAGE
92
PharmaCompass offers a list of Sodium Glycerophosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sodium Glycerophosphate manufacturer or Sodium Glycerophosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Glycerophosphate manufacturer or Sodium Glycerophosphate supplier.
PharmaCompass also assists you with knowing the Sodium Glycerophosphate API Price utilized in the formulation of products. Sodium Glycerophosphate API Price is not always fixed or binding as the Sodium Glycerophosphate Price is obtained through a variety of data sources. The Sodium Glycerophosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A PERIKABIVEN IN PLASTIC CONTAINER-6 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of PERIKABIVEN IN PLASTIC CONTAINER-6, including repackagers and relabelers. The FDA regulates PERIKABIVEN IN PLASTIC CONTAINER-6 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. PERIKABIVEN IN PLASTIC CONTAINER-6 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of PERIKABIVEN IN PLASTIC CONTAINER-6 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A PERIKABIVEN IN PLASTIC CONTAINER-6 supplier is an individual or a company that provides PERIKABIVEN IN PLASTIC CONTAINER-6 active pharmaceutical ingredient (API) or PERIKABIVEN IN PLASTIC CONTAINER-6 finished formulations upon request. The PERIKABIVEN IN PLASTIC CONTAINER-6 suppliers may include PERIKABIVEN IN PLASTIC CONTAINER-6 API manufacturers, exporters, distributors and traders.
click here to find a list of PERIKABIVEN IN PLASTIC CONTAINER-6 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A PERIKABIVEN IN PLASTIC CONTAINER-6 DMF (Drug Master File) is a document detailing the whole manufacturing process of PERIKABIVEN IN PLASTIC CONTAINER-6 active pharmaceutical ingredient (API) in detail. Different forms of PERIKABIVEN IN PLASTIC CONTAINER-6 DMFs exist exist since differing nations have different regulations, such as PERIKABIVEN IN PLASTIC CONTAINER-6 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A PERIKABIVEN IN PLASTIC CONTAINER-6 DMF submitted to regulatory agencies in the US is known as a USDMF. PERIKABIVEN IN PLASTIC CONTAINER-6 USDMF includes data on PERIKABIVEN IN PLASTIC CONTAINER-6's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The PERIKABIVEN IN PLASTIC CONTAINER-6 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of PERIKABIVEN IN PLASTIC CONTAINER-6 suppliers with USDMF on PharmaCompass.
A PERIKABIVEN IN PLASTIC CONTAINER-6 CEP of the European Pharmacopoeia monograph is often referred to as a PERIKABIVEN IN PLASTIC CONTAINER-6 Certificate of Suitability (COS). The purpose of a PERIKABIVEN IN PLASTIC CONTAINER-6 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of PERIKABIVEN IN PLASTIC CONTAINER-6 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of PERIKABIVEN IN PLASTIC CONTAINER-6 to their clients by showing that a PERIKABIVEN IN PLASTIC CONTAINER-6 CEP has been issued for it. The manufacturer submits a PERIKABIVEN IN PLASTIC CONTAINER-6 CEP (COS) as part of the market authorization procedure, and it takes on the role of a PERIKABIVEN IN PLASTIC CONTAINER-6 CEP holder for the record. Additionally, the data presented in the PERIKABIVEN IN PLASTIC CONTAINER-6 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the PERIKABIVEN IN PLASTIC CONTAINER-6 DMF.
A PERIKABIVEN IN PLASTIC CONTAINER-6 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. PERIKABIVEN IN PLASTIC CONTAINER-6 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of PERIKABIVEN IN PLASTIC CONTAINER-6 suppliers with CEP (COS) on PharmaCompass.
A PERIKABIVEN IN PLASTIC CONTAINER-6 written confirmation (PERIKABIVEN IN PLASTIC CONTAINER-6 WC) is an official document issued by a regulatory agency to a PERIKABIVEN IN PLASTIC CONTAINER-6 manufacturer, verifying that the manufacturing facility of a PERIKABIVEN IN PLASTIC CONTAINER-6 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting PERIKABIVEN IN PLASTIC CONTAINER-6 APIs or PERIKABIVEN IN PLASTIC CONTAINER-6 finished pharmaceutical products to another nation, regulatory agencies frequently require a PERIKABIVEN IN PLASTIC CONTAINER-6 WC (written confirmation) as part of the regulatory process.
click here to find a list of PERIKABIVEN IN PLASTIC CONTAINER-6 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing PERIKABIVEN IN PLASTIC CONTAINER-6 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for PERIKABIVEN IN PLASTIC CONTAINER-6 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture PERIKABIVEN IN PLASTIC CONTAINER-6 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain PERIKABIVEN IN PLASTIC CONTAINER-6 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a PERIKABIVEN IN PLASTIC CONTAINER-6 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of PERIKABIVEN IN PLASTIC CONTAINER-6 suppliers with NDC on PharmaCompass.
PERIKABIVEN IN PLASTIC CONTAINER-6 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of PERIKABIVEN IN PLASTIC CONTAINER-6 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right PERIKABIVEN IN PLASTIC CONTAINER-6 GMP manufacturer or PERIKABIVEN IN PLASTIC CONTAINER-6 GMP API supplier for your needs.
A PERIKABIVEN IN PLASTIC CONTAINER-6 CoA (Certificate of Analysis) is a formal document that attests to PERIKABIVEN IN PLASTIC CONTAINER-6's compliance with PERIKABIVEN IN PLASTIC CONTAINER-6 specifications and serves as a tool for batch-level quality control.
PERIKABIVEN IN PLASTIC CONTAINER-6 CoA mostly includes findings from lab analyses of a specific batch. For each PERIKABIVEN IN PLASTIC CONTAINER-6 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
PERIKABIVEN IN PLASTIC CONTAINER-6 may be tested according to a variety of international standards, such as European Pharmacopoeia (PERIKABIVEN IN PLASTIC CONTAINER-6 EP), PERIKABIVEN IN PLASTIC CONTAINER-6 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (PERIKABIVEN IN PLASTIC CONTAINER-6 USP).
